On January 14th, long-time board director Mark Demilio completed the sale of 2,254 RH shares in a single transaction valued at $495,880, reducing his personal stake by 10.15%. Following the sale, Demilio’s holdings stand at 19,962 shares, worth approximately $4.39 million, marking a notable shift in insider positioning as disclosed in an SEC filing.

In its December quarter, RH reported revenue of $883.81 million, up 8.9% year-over-year and essentially in line with consensus, but posted earnings per share of $1.71 against analyst forecasts of $2.13. The company generated a net margin of 3.22% and recorded a negative return on equity of 161.72%, while sell-side analysts project full-year EPS of 4.39, underscoring a gap between revenue momentum and profitability challenges.

Investor sentiment remains mixed: Morgan Stanley lifted its target to $275, offering upside to current consensus, while other firms maintain a median price target near $200. Among 21 recent ratings, nine are Buy, eight Hold and four Sell. Institutional investors and hedge funds hold 90.17% of shares, with notable position changes by several large asset managers, reflecting both conviction and caution in RH’s near-term outlook.